RestoreX & Penile Rehabilitation Devices
Mechanical Penile Traction with Randomized Evidence in Peyronie's and Post-Prostatectomy Settings
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Marketed as a medical device for penile traction; specific indication claims vary
Reference only. Not medical advice.
What can go wrong
Traction requires correct, consistent use; misuse can cause bruising, discomfort, skin irritation, or temporary numbness. Reported gains are modest and depend on adherence. Some evidence comes from single-center trials with the device's developers involved, so independent replication is valuable. Men with active genital infection, untreated disease, or uncertainty about diagnosis should be evaluated by a urologist before use, and Peyronie's and post-prostatectomy use should be physician-directed.
This is something to take to a clinician. The Atlas can tell you what is known about restorex & penile rehabilitation devices in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
RestoreX is a clinician-developed penile traction device that distinguishes itself from older cosmetic 'penis extenders' by carrying randomized controlled evidence in medical settings. Developed by urologists at Mayo Clinic, it applies counter-bending and axial traction and is studied for Peyronie's disease (reducing curvature and length loss) and for penile rehabilitation after radical prostatectomy (recovering penile length and improving erectile function). It typically requires structured daily use of roughly 30 to 90 minutes over months. The mechanism is mechanotransduction: sustained tension counters fibrosis and stimulates tissue lengthening. Reported gains are modest but, unlike generic extenders, are supported by randomized data in defined clinical populations rather than enhancement marketing.
The traction device that moved from enhancement folklore toward the clinic, with randomized data in Peyronie's and after prostatectomy.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
- Peyronie's disease (adjunct)
- Used to reduce curvature and counter length loss, often combined with collagenase injections or perioperatively; note the 2015 AUA guideline judged traction evidence insufficient to recommend at that time, while newer randomized data are more favorable and ISSM recognizes traction.
- Post-prostatectomy penile rehabilitation
- Used to recover penile length and improve erectile function after radical prostatectomy, the setting with the strongest randomized evidence for this device.
- General length preservation
- Applied in some rehabilitation protocols to limit shortening; gains for healthy men seeking enhancement are modest and should not be overstated.
How it is supposed to work
Sustained axial traction (and, in Peyronie's, directional counter-bending) applies tension that stimulates mechanotransduction pathways promoting tissue growth and remodeling while opposing fibrotic contracture. In Peyronie's disease this aims to reduce curvature and recover length lost to plaque tethering; after prostatectomy it aims to counter corporal fibrosis from the rehabilitation-period loss of erections, recovering stretched length and supporting erectile function. Adherence to the daily wear schedule is essential to any benefit.
Penile traction works by mechanotransduction: sustained mechanical tension on the tunica albuginea and corporal tissue stimulates cellular signaling that favors tissue lengthening and remodeling, and counters the collagen contracture that drives Peyronie's curvature and post-surgical shortening. RestoreX differs mechanically from sleeve-and-rod cosmetic extenders by anchoring at the penile base and allowing directional counter-bending against a curvature, which is the rationale for its use in Peyronie's disease.
Safety in detail
Penile traction with RestoreX should be used under urological guidance, particularly for Peyronie's disease and post-prostatectomy rehabilitation. Incorrect use can cause injury, much of the supporting evidence is from single-center trials, and benefits are modest. It is a medical adjunct, not a guaranteed enhancement or cure.
What people get wrong
Often saidRestoreX is just a branded penis extender for enlargement
ActuallyUnlike generic cosmetic extenders, RestoreX has randomized evidence in defined medical settings (Peyronie's and post-prostatectomy). Its documented gains are modest and disease-specific, not large enhancement claims.
Often saidTraction works without consistent daily use
ActuallyBenefit depends on sustained adherence to a daily wear schedule over months; sporadic use is unlikely to produce the studied effects.
Often saidThe evidence settles that traction cures Peyronie's
ActuallyRandomized data are encouraging but from limited single-center trials, and the 2015 AUA guideline predated much of it and judged traction evidence insufficient. It is best viewed as an evidence-supported adjunct, not a cure.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
How we got here
Penile traction grew out of decades of cosmetic 'penis extender' devices with weak evidence. The clinical reframing came when Mayo Clinic urologists developed RestoreX with a base anchor and directional counter-bending and subjected it to randomized trials, first in Peyronie's disease and then in the post-prostatectomy rehabilitation setting, distinguishing it from the enhancement-marketing lineage of earlier traction products.
At a glance
- Type
- Clinician-developed penile traction device
- Developer
- Urologists at Mayo Clinic
- Studied settings
- Peyronie's disease; post-prostatectomy rehabilitation
- Typical use
- Around 30 to 90 minutes daily over months
- Mechanism
- Mechanotransduction (tension-induced tissue remodeling)
- Distinction
- Randomized evidence, unlike generic extenders
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about RestoreX & Penile Rehabilitation Devices. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Single-center randomized controlled trial in Peyronie's diseasearound 2019
RestoreX traction was reported to reduce penile curvature and improve or recover length versus controls, providing randomized evidence in a condition where older traction data were weak.
Single-center randomized controlled trial post-prostatectomy (Journal of Urology)around 2021
In roughly 80 men, daily RestoreX traction significantly improved penile length (about 1.5 cm or more) and erectile function versus controls, with maintained benefit in the open-label extension and high willingness to repeat the therapy.